- Resveratrol as an Adjuvant for Normal Tissues Protection and Tumor Sensitization
Keywan Mortezaee et al, 2020, Current Cancer Drug Targets CrossRef - Role of Resveratrol in Chemosensitization of Cancer
Sabira Mohammed et al, 2018, Role of Nutraceuticals in Chemoresistance to Cancer CrossRef - 3,4′,5-trans-Trimethoxystilbene; a natural analogue of resveratrol with enhanced anticancer potency
Fahad S. Aldawsari et al, 2015, Investigational New Drugs CrossRef - Curcumin Affects Phase II Disposition of Resveratrol Through Inhibiting Efflux Transporters MRP2 and BCRP
Shufan Ge et al, 2016, Pharmaceutical Research CrossRef - Modulatory potential of resveratrol during lung inflammatory disease
José Eduardo Vargas et al, 2016, Medical Hypotheses CrossRef - Oral or parenteral administration of curcumin does not prevent the growth of high-risk t(4;11) acute lymphoblastic leukemia cells engrafted into a NOD/SCID mouse model
SUSAN J. ZUNINO et al, 2013, International Journal of Oncology CrossRef - The Multiple Mechanisms of Cell Death Triggered by Resveratrol in Lymphoma and Leukemia
Raffaele Frazzi et al, 2014, International Journal of Molecular Sciences CrossRef - Pleiotropic Molecular Effects of Dietary Polyphenols Resveratrol and Apigenin in Leukemia
Aysun Adan et al, 2018, Polyphenols: Prevention and Treatment of Human Disease CrossRef - Pterostilbene downregulates BCR/ABL and induces apoptosis of T315I-mutated BCR/ABL-positive leukemic cells
Shohei Kawakami et al, 2022, Scientific Reports CrossRef - Resveratrol ameliorates toxic effects of cadmium on placental development in mouse placenta and human trophoblast cells
Wenjie Wang et al, 2021, Birth Defects Research CrossRef - Biological Mechanisms by Which Antiproliferative Actions of Resveratrol Are Minimized
Yih Ho et al, 2017, Nutrients CrossRef - Physiological Levels of Resveratrol Metabolites are Ineffective as Anti-Leukemia Agents Against Jurkat Leukemia Cells
Susan J. Zunino et al, 2015, Nutrition and Cancer CrossRef